On Friday, DENTSPLY Sirona Inc (NASDAQ: XRAY) opened higher 1.38% from the last session, before settling in for the closing price of $23.17. Price fluctuations for XRAY have ranged from $22.85 to $37.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 0.88%. Company’s average yearly earnings per share was noted 8.16% at the time writing. With a float of $201.14 million, this company’s outstanding shares have now reached $207.20 million.
Let’s determine the extent of company efficiency that accounts for 15000 employees. In terms of profitability, gross margin is 52.26%, operating margin of -2.41%, and the pretax margin is -5.13%.
DENTSPLY Sirona Inc (XRAY) Insider Activity
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of DENTSPLY Sirona Inc is 0.78%, while institutional ownership is 105.79%. The most recent insider transaction that took place on Aug 08 ’24, was worth 199,983. In this transaction Director of this company bought 8,212 shares at a rate of $24.35, taking the stock ownership to the 66,661 shares. Before that another transaction happened on May 31 ’24, when Company’s Director bought 3,577 for $27.95, making the entire transaction worth $99,976. This insider now owns 58,374 shares in total.
DENTSPLY Sirona Inc (XRAY) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 8.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.27% during the next five years compared to 32.70% growth over the previous five years of trading.
DENTSPLY Sirona Inc (NASDAQ: XRAY) Trading Performance Indicators
Check out the current performance indicators for DENTSPLY Sirona Inc (XRAY). In the past quarter, the stock posted a quick ratio of 0.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.24. Likewise, its price to free cash flow for the trailing twelve months is 13.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.87, a number that is poised to hit 0.47 in the next quarter and is forecasted to reach 2.28 in one year’s time.
Technical Analysis of DENTSPLY Sirona Inc (XRAY)
Looking closely at DENTSPLY Sirona Inc (NASDAQ: XRAY), its last 5-days average volume was 2.63 million, which is a drop from its year-to-date volume of 2.96 million. As of the previous 9 days, the stock’s Stochastic %D was 26.62%. Additionally, its Average True Range was 0.66.
During the past 100 days, DENTSPLY Sirona Inc’s (XRAY) raw stochastic average was set at 12.46%, which indicates a significant decrease from 30.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 26.38% in the past 14 days, which was lower than the 31.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $25.08, while its 200-day Moving Average is $28.38. However, in the short run, DENTSPLY Sirona Inc’s stock first resistance to watch stands at $23.74. Second resistance stands at $23.98. The third major resistance level sits at $24.31. If the price goes on to break the first support level at $23.16, it is likely to go to the next support level at $22.83. Should the price break the second support level, the third support level stands at $22.59.
DENTSPLY Sirona Inc (NASDAQ: XRAY) Key Stats
There are currently 202,714K shares outstanding in the company with a market cap of 4.83 billion. Presently, the company’s annual sales total 3,965 M according to its annual income of -132,000 K. Last quarter, the company’s sales amounted to 984,000 K and its income totaled -4,000 K.
